Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Tran Thi Thuy Duong *Institute of Microbiology and Immunology, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Wei-Hung Lin *Division of Nephrology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Ya-Min Tsai *Department of Clinical Laboratory, En Chu Kong Hospital, New Taipei City, Taiwan.
Chun-Hsing LiaoDivision of Infectious Diseases, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Yun-Tsung HuangDepartment of Laboratory Medicine and Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Po-Ren HsuehDepartments of Laboratory Medicine and Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Cheng-Yen KaoInstitute of Microbiology and Immunology, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.ORCID 0000-0001-8782-3912
Funding
En Chu Kong Hospital ECKH_W11303National Science and Technology Council 112-2320-B-A49-045-MY3National Science and Technology Council 113-2314-B-002-129-National Science and Technology Council 113-2628-B-A49-011-MY3National Science and Technology Council 114-2314-B-006-072-MY3National Science and Technology Council 114-2635-B-385-001-National Science and Technology Council 114-2740-B-A49-003-Yen Tjing Ling Medical Foundation CI-113-29
6 · The paper itself
Abstract
We integrated genetic and phenotypic analyses to characterize carbapenem-resistant hypervirulent
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A combined genetic and phenotypic marker approach enables precise detection of hypervirulent · full record | OpenQuestion